Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Muscle-derived interleukin 6 increases exercise capacity by signaling in osteoblasts
Subrata Chowdhury, … , Jens Brüning, Gerard Karsenty
Subrata Chowdhury, … , Jens Brüning, Gerard Karsenty
Published February 20, 2020
Citation Information: J Clin Invest. 2020;130(6):2888-2902. https://doi.org/10.1172/JCI133572.
View: Text | PDF
Research Article Bone biology

Muscle-derived interleukin 6 increases exercise capacity by signaling in osteoblasts

  • Text
  • PDF
Abstract

Given the numerous health benefits of exercise, understanding how exercise capacity is regulated is a question of paramount importance. Circulating interleukin 6 (IL-6) levels surge during exercise and IL-6 favors exercise capacity. However, neither the cellular origin of circulating IL-6 during exercise nor the means by which this cytokine enhances exercise capacity has been formally established yet. Here we show through genetic means that the majority of circulating IL-6 detectable during exercise originates from muscle and that to increase exercise capacity, IL-6 must signal in osteoblasts to favor osteoclast differentiation and the release of bioactive osteocalcin in the general circulation. This explains why mice lacking the IL-6 receptor only in osteoblasts exhibit a deficit in exercise capacity of similar severity to the one seen in mice lacking muscle-derived IL-6 (mIL-6), and why this deficit is correctable by osteocalcin but not by IL-6. Furthermore, in agreement with the notion that IL-6 acts through osteocalcin, we demonstrate that mIL-6 promotes nutrient uptake and catabolism into myofibers during exercise in an osteocalcin-dependent manner. Finally, we show that the crosstalk between osteocalcin and IL-6 is conserved between rodents and humans. This study provides evidence that a muscle-bone-muscle endocrine axis is necessary to increase muscle function during exercise in rodents and humans.

Authors

Subrata Chowdhury, Logan Schulz, Biagio Palmisano, Parminder Singh, Julian M. Berger, Vijay K. Yadav, Paula Mera, Helga Ellingsgaard, Juan Hidalgo, Jens Brüning, Gerard Karsenty

×

Figure 6

IL-6 signaling in osteoblasts is needed to enhance exercise capacity during endurance exercise.

Options: View larger image (or click on image) Download as PowerPoint
IL-6 signaling in osteoblasts is needed to enhance exercise capacity dur...
(A) Crossing of Il6rfl/fl mice with Ocn-Cre mice to delete Il6r in differentiated osteoblasts after birth and generate Il6rOsb–/– mice. (B) Detection of Il6r deletion by PCR on genomic DNA isolated from various tissues of Il6rOsb–/– mice. (C) Circulating IL-6 levels in 3-month-old Il6rfl/fl and Il6rOsb–/– mice before and after exercise, n = 8. (D) Performance during an endurance run of 3- and 6-month-old Il6rfl/fl and Il6rOsb–/– mice, n = 12–18. (E) Performance during an endurance run of 3-month-old Il6rfl/fl and Il6rHsa–/– mice, n = 7–9. (F) Circulating Ocn levels at rest and after exercise in bones of 3-month-old Il6rfl/fl and Il6rOsb–/– mice, n = 9–10. (G) Performance during an endurance run of 3-month-old control (Il6rOsb+/–, Ocn+/–, and WT) and Ocn+/– Il6rOsb+/– mice, n = 7–13. (H) Circulating Ocn levels in 3-month-old controls (WT, Il6rOsb+/–, and Ocn+/–) and Ocn+/– Il6rOsb+/– mice at rest and after exercise, n = 10 each. These results are representative of 4 independent experiments. Data were analyzed by 1-way ANOVA followed by Tukey’s post hoc test. Data presented as the mean ± SEM. *P < 0.05; **P < 0.01.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts